Y
Yu Chen
Researcher at Huazhong University of Science and Technology
Publications - 9
Citations - 167
Yu Chen is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Ulcerative colitis & Epidemiology. The author has an hindex of 3, co-authored 9 publications receiving 94 citations.
Papers
More filters
Journal ArticleDOI
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.
Cong Ye,Shaozhe Cai,Guifen Shen,Hanxiong Guan,Liling Zhou,Yangyang Hu,Wei Tu,Yu Chen,Yikai Yu,Xuefen Wu,Yuxue Chen,Jixin Zhong,Lingli Dong +12 more
TL;DR: Rheumatic patients diagnosed with COVID-19 presented with similar radiological features of ground-glass opacity and consolidation, and patients with pre-existing interstitial lung disease showed massive fibrous stripes and crazy-paving signs at an early stage.
Journal ArticleDOI
Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20.
TL;DR: HA20 is characterized by early-onset and the most common symptoms of HA20 are recurrent oral ulcers, fever and gastrointestinal ulcers and the ZnF domain may be more closely related to musculoskeletal disorders.
Journal ArticleDOI
Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019.
TL;DR: The epidemic of COVID-19 might have a certain impact on many aspects of Hubei IBD patients within four weeks of traffic control after the outbreak, and doctors could utilize the results from the questionnaire to guide patients’ self-management.
Journal ArticleDOI
A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report.
TL;DR: It is proposed that the TNFAIP3 heterozygous mutation with an insufficient expression of A20 may be associated with the iBD phenotype in patients, and this patient was described as a 29-year-old female with iBD-like symptoms.
Journal ArticleDOI
Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China.
TL;DR: IgG4-RD patients may belongs to the susceptible population of COVID-19 infection, and thus need more careful personal protection.